Nutriflex Basal

Valine, the active ingredient in Nutriflex Basal, is a branched‑chain amino acid presented as a nutritional supplement for oral use. It supports protein synthesis and metabolic balance in patients requiring specialized nutrition support.

GNH USA supplies Nutriflex Basal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.

Nutriflex Basal provides essential amino acids for patients with increased metabolic demand or limited oral intake. It is used in: - Critical illness: helps maintain lean body mass and supports recovery. - Post‑operative care: aids wound healing and nitrogen balance. - Chronic malnutrition: supplies necessary building blocks for protein synthesis.

Adverse reactions are generally mild and related to the oral formulation.

Common Side Effects: - Nausea: occasional upset stomach. - Diarrhea: loose stools in some patients. - Metallic taste: transient alteration in taste perception. - Abdominal discomfort: mild cramping or bloating. - Headache: mild, self‑limiting.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, or swelling. - Hyperammonemia: elevated ammonia levels in susceptible individuals. - Metabolic acidosis: rare disturbance of acid‑base balance. - Severe gastrointestinal intolerance: persistent vomiting or severe diarrhea. - Anaphylaxis: immediate hypersensitivity requiring emergency care.

When prescribing Nutriflex Basal, consider the following safety measures: - Renal impairment: adjust dosage based on kidney function. - Hepatic dysfunction: monitor liver enzymes regularly. - Metabolic disorders: assess risk of nitrogen overload. - Pregnancy and lactation: use only if clearly needed. - Drug interactions: review concomitant medications for amino‑acid related effects. - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Nutriflex Basal may interact with several drug classes. Clinical awareness is required.

Major Interactions (Avoid): - High‑dose levothyroidine: may exacerbate hypermetabolic state. - Nitrogen‑bearing drugs (e.g., valproate, phenylacetate).

Moderate Interactions (Monitor Closely): - Diuretics: can affect electrolyte balance. - Insulin and oral hypoglycemics: may alter glucose control. - Anticonvulsants: potential for altered amino‑acid metabolism. - Corticosteroids: increased protein catabolism risk.